Opendata, web and dolomites


Promoting Osteogenesis through Vascular Endothelial Cells

Total Cost €


EC-Contrib. €






 PROVEC project word cloud

Explore the words cloud of the PROVEC project. It provides you a very rough idea of what is the project "PROVEC" about.

microscopy    diseased    rna    systemically    patients    induce    completion    ambitions    combination    ecs    mouse    endothelial    million    sufficient    euros    functional    models    mineral    micro    confocal    expression    treatments    signaling    osteoclasts    monitored    billion    hypoxia    health    diseases    appropriate    annual    biology    trigger    osteoblast    capillaries    gene    generate    relevance    regeneration    27    computational    genetics    powerful    genetic    therapeutic    cultures    inducible    notch    bone    regenerating    skeletal    vascular    successful    mice    alone    ct    vasculature    lineage    manipulation    form    modulation    aging    3d    specialization    cell    cultured    disease    cells    fate    density    human    animals    sequencing    preclinical    single    generates    transplantation    regulation    animal    subpopulations    pharmacological    endowed    seq    beneficial    crosstalk    found    heterogeneity    organization    osteoporosis    healthy    provec    expansion    osteoblasts    living    thereby    fundamental    organoid    photon    37    imaging    osteoprogenitors    lack    insights    mapping   

Project "PROVEC" data sheet

The following table provides information about the project.


Organization address
postcode: 80539
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Total cost 2˙205˙875 €
 EC max contribution 2˙205˙875 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2017-ADG
 Funding Scheme ERC-ADG
 Starting year 2019
 Duration (year-month-day) from 2019-02-01   to  2024-01-31


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 


 Project objective

The skeletal system and its vasculature form a functional unit with great relevance in health, regeneration, and disease. Our recent work has provided fundamental insights into the organization of the bone vasculature in mouse, its changes during aging, the heterogeneity and functional specialization of bone capillaries and endothelial cells, the regulation of these properties by Notch and hypoxia-inducible factor signaling, and the crosstalk with osteoblast lineage cells. Most importantly, we found that the manipulation of ECs in the aging animal can trigger the expansion of osteoprogenitors and thereby induce bone formation. PROVEC will now systemically identify and characterize endothelial cell subpopulations, their gene expression and functional properties in the healthy, aging, diseased and regenerating skeletal system. Preclinical models will establish whether endothelial cells are involved in the response to therapeutic treatments aiming at osteoblasts or osteoclasts, or if the modulation of ECs alone is sufficient to generate beneficial effects. Finally, PROVEC will investigate whether cultured mouse and human ECs can be endowed with beneficial properties to enhance bone formation in 3D organoid cultures and after transplantation into mice, which will be monitored by imaging in living animals. To achieve its ambitions aims, PROVEC will use a powerful combination of mouse genetics, disease models, genetic fate mapping, RNA-seq and single cell sequencing, computational biology, confocal and 2-photon microscopy, micro-CT imaging, pharmacological treatments, and cell biology methods to establish if and how vascular endothelial cells can be used to increase bone mineral density in preclinical models. The successful completion of PROVEC would be highly relevant for diseases such as osteoporosis, which affects around 27.5 million patients in the EU, generates annual costs of about 37 billion Euros, and for which we currently lack appropriate treatments.


year authors and title journal last update
List of publications.
2020 Kishor K Sivaraj, Backialakshmi Dharmalingam, Vishal Mohanakrishnan, Hyun-Woo Jeong, Katsuhiro Kato, Silke Schröder, Susanne Adams, Gou Young Koh, Ralf H Adams
YAP1 and TAZ negatively control bone angiogenesis by limiting hypoxia-inducible factor signaling in endothelial cells
published pages: , ISSN: 2050-084X, DOI: 10.7554/elife.50770
eLife 9 2020-02-06

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PROVEC" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PROVEC" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

CohoSing (2019)

Cohomology and Singularities

Read More  

EAST (2020)

Using Evolutionary Algorithms to Understand and Secure Web/Enterprise Systems

Read More  


Co-production of seasonal representations for adaptive institutions

Read More